Alignment Healthcare president sells 177K shares

Alignment Healthcare, Inc. president Dawn Christine Maroney reported an option exercise and related stock sale.

Rhea-AI Filing Summary

Alignment Healthcare, Inc. president Dawn Christine Maroney reported an option exercise and related stock sale. She exercised options to acquire 152,068 shares of common stock at $9.0600 per share and sold 177,068 shares in open-market transactions at a weighted-average price of $20.8281 per share under a Rule 10b5-1 trading plan adopted on 3/13/26, with individual sale prices ranging from $20.29 to $21.14. The exercised options, granted on 03/08/2022, vested 25% on each of the first four anniversaries of the grant date.

Insider Trade Summary 10b5-1

Exercise and sale activity reported; no spread calculated

Exercise and Sale 3 txns

Insider Maroney Dawn Christine

Role President

Sold 177,068 shs ($3.69M)

Approx. gross sale proceeds $3.69M

Approx. exercise cost $1.38M

Type	Security	Shares	Price	Value
Exercise	Options (Right to Buy) F3	152,068	$9.06	$1.38M
Exercise	Common Stock F1	152,068	$9.06	$1.38M
Sale	Common Stock F1, F2	177,068	$20.8281	$3.69M

Holdings After Transaction: Options (Right to Buy) — 0 contracts (Direct); Common Stock — 922,313 shares (Direct)

Footnotes (3)

1. F1. Date of adoption of Rule 10b5-1 plan: 3/13/26
2. F2. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $20.29 to $21.14. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
3. F3. Options vested 25% on each of the first four anniversaries of the grant date (03/08/2022), subject to the reporting person's continued service to the Company as of the applicable vesting date.

Key Figures

Shares sold: 177,068 shares Sale weighted-average price: $20.8281 per share Options exercised: 152,068 shares +3 more

6 metrics

Shares sold 177,068 shares Open-market sale of common stock on 2026-07-15

Sale weighted-average price $20.8281 per share Weighted-average price for common stock sold on 2026-07-15

Options exercised 152,068 shares Shares acquired through option exercise on 2026-07-15

Option exercise price $9.0600 per share Exercise price for Options (Right to Buy) into common stock

Option expiration 2032-03-08 Expiration date of the exercised options grant

Sale price range $20.29–$21.14 per share Range of individual open-market sale prices on 2026-07-15

Key Terms

Rule 10b5-1 plan, weighted-average price, derivative security, Options (Right to Buy)

4 terms

Rule 10b5-1 plan regulatory

"Date of adoption of Rule 10b5-1 plan: 3/13/26"

A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

weighted-average price financial

"The reported price in column 4 is a weighted-average price."

Weighted-average price is the average of multiple prices where each price is counted according to its size or importance—larger trades carry more weight than smaller ones, like averaging course grades by credit hours. It matters to investors because it gives a more realistic picture of the true price paid or received, helping assess trade execution, compare performance, calculate cost basis, and value positions more accurately than a simple average.

derivative security financial

"Exercise or conversion of derivative security"

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

Options (Right to Buy) financial

"security_title: Options (Right to Buy)"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did ALHC president Dawn Christine Maroney report?

Dawn Christine Maroney reported exercising options for 152,068 shares of Alignment Healthcare common stock at $9.0600 per share and selling 177,068 shares in open-market transactions at a $20.8281 weighted-average price on July 15, 2026, under a Rule 10b5-1 plan.

How many Alignment Healthcare (ALHC) shares did Dawn Maroney sell and at what price?

She sold 177,068 shares of Alignment Healthcare common stock. The reported sale price was a weighted-average of $20.8281 per share, executed through multiple open-market trades on July 15, 2026, with individual prices between $20.29 and $21.14.

Did Dawn Maroney’s ALHC stock sales occur under a Rule 10b5-1 plan?

Yes. A footnote states that the transactions were made under a Rule 10b5-1 trading plan adopted on 3/13/26. Such plans pre-arrange trades, meaning the timing of Maroney’s July 15, 2026 sales was set in advance rather than decided opportunistically.

What options did Dawn Maroney exercise in Alignment Healthcare (ALHC) stock?

She exercised options covering 152,068 shares of Alignment Healthcare common stock at an exercise price of $9.0600 per share. These options, granted on 03/08/2022, were scheduled to vest 25% on each of the first four anniversaries of the grant date.

Over what price range were Dawn Maroney’s ALHC shares sold?

Although the reported sale price is a $20.8281 weighted-average, a footnote explains that the 177,068 shares were sold in multiple transactions, with individual trade prices ranging from $20.29 to $21.14 per share on July 15, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/16/2026 - 04:54 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Maroney Dawn Christine

(Last) (First) (Middle)

1100 W. TOWN & COUNTRY RD.

SUITE 1600

(Street)

ORANGE CALIFORNIA 92868

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Alignment Healthcare, Inc. [ ALHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/15/2026		M(1)		152,068	A	$9.06	1,099,381	D
Common Stock	07/15/2026		S(1)		177,068	D	$20.8281(2)	922,313	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options (Right to Buy)	$9.06	07/15/2026		M			152,068	(3)	03/08/2032	Common Stock	152,068	$9.06	0	D

Explanation of Responses:

1. Date of adoption of Rule 10b5-1 plan: 3/13/26

2. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $20.29 to $21.14. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

3. Options vested 25% on each of the first four anniversaries of the grant date (03/08/2022), subject to the reporting person's continued service to the Company as of the applicable vesting date.

Remarks:

	/s/ Christopher J. Joyce, as Attorney-in-Fact, for Dawn C. Maroney	07/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)